<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02670863</url>
  </required_header>
  <id_info>
    <org_study_id>14.15.INF</org_study_id>
    <nct_id>NCT02670863</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study</brief_title>
  <official_title>Safety and Efficacy of a New Term Infant Formula Supplemented With A Prebiotic: a Doubleblind, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the experimental formula&#xD;
      supplemented with a prebiotic vs the control formula.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, double-blind, controlled interventional clinical trial design. The purpose of&#xD;
      this study is to evaluate the safety and efficacy of a new term infant formula supplemented&#xD;
      with a prebiotic vs a standard infant formula fed for 150 days to healthy, term infants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 21, 2016</start_date>
  <completion_date type="Actual">May 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Growth</measure>
    <time_frame>150 days</time_frame>
    <description>weight gain velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stool Consistency Score</measure>
    <time_frame>150 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>150 days</time_frame>
    <description>weight in grams</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Daily Stool Frequency</measure>
    <time_frame>150 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Microbiota</measure>
    <time_frame>150 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Markers</measure>
    <time_frame>150 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>150 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">239</enrollment>
  <condition>Infant Term Birth</condition>
  <arm_group>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental Infant Formula containing a prebiotic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Infant Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard bovine milk-based term infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Infant Formula</intervention_name>
    <description>Standard bovine milk-based term infant formula supplemented with a prebiotic, fed ad libitum</description>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Infant Formula</intervention_name>
    <description>Standard bovine milk-based term infant formula, fed ad libitum</description>
    <arm_group_label>Standard Infant Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written Informed Consent&#xD;
&#xD;
          -  Infants whose parent(s)/LAR have reached the legal age of majority in the Philippines&#xD;
&#xD;
          -  Infants whose parent(s)/LAR are willing and able to comply with study requirements&#xD;
&#xD;
          -  Infants whose parent(s)/LAR are able to be contacted by telephone throughout the study&#xD;
&#xD;
          -  Healthy term, singleton infant at birth&#xD;
&#xD;
          -  Between 21 to 26 days post-natal age at enrollment visit&#xD;
&#xD;
          -  Weight-for-length and head circumference-for-age z-scores &gt;/= - 3 and &lt;/= +3 according&#xD;
             to WHO Child Growth Standards&#xD;
&#xD;
          -  Infants of parent(s)/LAR who have previously made the decision to formula feed their&#xD;
             infant at the time of enrollment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infants with conditions requiring infant feedings other than those specified in the&#xD;
             protocol&#xD;
&#xD;
          -  Infants receiving complementary foods or liquids&#xD;
&#xD;
          -  Infants who have a medical condition or history that could increase the risk&#xD;
             associated with study participation or interfere with the interpretation of study&#xD;
             results&#xD;
&#xD;
          -  Infants who are presently receiving or have received medications that could interfere&#xD;
             with the interpretation of study results&#xD;
&#xD;
          -  Infants or infants whose parents/LAR cannot be expected to comply with the protocol or&#xD;
             with study procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>26 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elvira M Estorninos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asian Hospital and Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asian Hospital and Medical Center</name>
      <address>
        <city>Muntinlupa</city>
        <zip>1780</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 20, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2016</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

